Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spring Bank Pharmaceuticals, Inc. | 17,867 | reported | 20 Nov 2020 | tx 4+16,250−3,925 |
| Galecto, Inc. | 726 | reported | 02 Jan 2026 | tx 11+19,474−2,017 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | EXERCISE | Galecto, Inc. | 374 | — | |
| 02 Jan 2026 | SALE | Galecto, Inc. | 135 | 21.41 USD | |
| 02 Jan 2026 | EXERCISE | Galecto, Inc. | 374 | 0.00 USD | deriv |
| 03 Jul 2025 | EXERCISE | Galecto, Inc. | 374 | — | |
| 03 Jul 2025 | SALE | Galecto, Inc. | 147 | 3.39 USD | |
| 03 Jul 2025 | EXERCISE | Galecto, Inc. | 374 | 0.00 USD | deriv |
| 03 Jan 2025 | EXERCISE | Galecto, Inc. | 726 | — | |
| 03 Jan 2025 | SALE | Galecto, Inc. | 261 | 5.63 USD | |
| 03 Jan 2025 | EXERCISE | Galecto, Inc. | 726 | 0.00 USD | deriv |
| 03 Jan 2025 | GRANT_AWARD | Galecto, Inc. | 5,000 | 0.00 USD | deriv |
| 09 Oct 2024 | GRANT_AWARD | Galecto, Inc. | 13,000 | 0.00 USD | deriv |
| 19 Nov 2020 | EXERCISE | Spring Bank Pharmaceuticals, Inc. | 3,750 | — | |
| 19 Nov 2020 | GRANT_AWARD | Spring Bank Pharmaceuticals, Inc. | 12,500 | — | |
| 20 Nov 2020 | SALE | Spring Bank Pharmaceuticals, Inc. | 175 | 4.76 USD | |
| 19 Nov 2020 | EXERCISE | Spring Bank Pharmaceuticals, Inc. | 3,750 | 0.00 USD | deriv |